Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
ConditionBreast Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age30-75
SponsorUniversity of Southern California
About this trial
This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.
Eligibility criteria
Qualifiers
* >= 30 years
=< 75 years
Genetic test results showing moderately increased breast cancer risk due to a pathogenic/likely pathogenic variant in ATM, CHEK2, BARD1, RAD51C, or RAD51D (Mutation carrier group) OR
Calculated lifetime breast cancer risk estimates between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model (Empiric risk group)
Disqualifiers
* History of breast cancer before genetic counseling at University of Southern California (USC)
Any metastatic cancer diagnosis at time of genetic counseling risk assessment
Deceased
Patient underwent a risk reducing mastectomy before their genetic counseling risk assessment
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
150 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov